Updates on other relevant pancreatic cancer and general cancer news.
Meet the Faculty Entrepreneur Developing a Cancer Drug with Fewer Side Effects
A company started by a University of Virginia faculty member is developing a drug with the potential to treat multiple cancers without the severe side effects of chemotherapy. The company, called iTi Health, was founded in 2010 by Kimberly Kelly, an associate professor of biomedical engineering. Dr. Kelly received a 2007 Career Development Award from PanCAN, which supported her initial work on plectin-1 expression in pancreatic cancer. She is also a member of our Emeritus Scientific & Medical Advisory Board.
Rolfe Pancreatic Cancer Foundation Announces Grant to Support Expansion of Online Early Detection Tools
The Rolfe Pancreatic Cancer Foundation, a leading Midwest institution with a mission of being a catalyst for the early detection and ultimate cure of pancreatic cancer, announced a $100,000 grant for Diane Simeone, M.D., Director of the Pancreatic Cancer Center at NYU Langone Medical Center, in partnership with genetic software company Progeny. The grant aims to strengthen a tablet-based pancreatic cancer family history tool to gather complete, detailed familial data and guide clinical care for patients and family members, while improving early detection testing criteria.
Northwestern University Pancreatic or Pulmonary Neuroendocrine or Carcinoid Tumor Study
Researchers from the Department of Medical Social Sciences at the Feinberg School of Medicine of Northwestern University, Chicago IL, are looking for people who have been diagnosed with a pancreatic or pulmonary neuroendocrine or carcinoid tumor to be part of a research study. Eligible people (18+ years) will be asked to participate in one 60-90-minute telephone interview to discuss their symptoms, side effects, and tumor-related concerns. Compensation is provided. This study is funded by the pharmaceutical company Ipsen. To learn more, please call Leilani Lacson at firstname.lastname@example.org or 312-503-3463 (9am-4pm, M-F, Central).
World’s Largest Gastrointestinal Cancer Congress to Highlight Advances and the Future of Care
What does the future hold for the prevention and care of patients with gastrointestinal cancers? The answer to this question and more will be highlighted from 28 June to 1 July at the ESMO 19th World Congress on Gastrointestinal Cancer (World GI Congress) in Barcelona, Spain.